Wasatch Global Investors, an investment management firm, published its “Wasatch Micro Cap Value Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. A return of 14.74% was recorded by the fund’s investor class for the Q1 of 2021, trailing the benchmark, Russell Microcap® Index, which leapt 23.89% for the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Wasatch Micro Cap Value Fund, in its Q1 2021 investor letter, mentioned Vireo Health International, Inc. (NYSE: VREOF), and shared their insights on the company. Vireo Health International, Inc. is a Minneapolis, Minnesota-based pharmaceutical company that currently has a $287.4 million market capitalization. Since the beginning of the year, VREOF delivered a 54.56% return, extending its 12-month gains to 366.67%. As of May 07, 2021, the stock closed at $2.27 per share.
Here is what Wasatch Micro Cap Value Fund has to say about Vireo Health International, Inc. in its Q1 2021 investor letter:
“The top contributor to Fund performance during the first quarter was Vireo Health International, Inc. (VREOF), a pharmaceutical company that cultivates medical cannabis and manufactures pharmaceutical-grade cannabis products. Vireo has licenses for distribution in the states of New York and Minnesota. The stock was up on news that politicians in both states appeared likely to be in favor of allowing expanded use of cannabis products. During the quarter, we exited our position in Vireo at the higher valuation.”
Our calculations show that Vireo Health International, Inc. (NYSE: VREOF) does not belong in our list of the 30 Most Popular Stocks Among Hedge Funds. VREOF delivered a -33.91% return in the past 3 months.
The top 10 stocks among hedge funds returned 231.2% between 2015 and 2020, and outperformed the S&P 500 Index ETFs by more than 126 percentage points. We know it sounds unbelievable. You have been dismissing our articles about top hedge fund stocks mostly because you were fed biased information by other media outlets about hedge funds’ poor performance. You could have doubled the size of your nest egg by investing in the top hedge fund stocks instead of dumb S&P 500 ETFs. Here you can watch our video about the top 5 hedge fund stocks right now. All of these stocks had positive returns in 2020.
At Insider Monkey, we scour multiple sources to uncover the next great investment idea. For example, Federal Reserve has been creating trillions of dollars electronically to keep the interest rates near zero. We believe this will lead to inflation and boost real estate prices. So, we recommended this real estate stock to our monthly premium newsletter subscribers. We go through lists like the 15 best innovative stocks to buy to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our website:
Disclosure: None. This article is originally published at Insider Monkey.